Suki

• Abridge: Worth prioritizing where documentation review and source-linked evidence are central requirements. Its platform also extends beyond notes; Suki’s claim that no other platform matches its breadth should not be accepted without a current feature comparison. Abridge reports deployment across hundreds of health systems, but that count is not directly comparable with Suki’s organization-and-partner counts (vendor claims).
• Microsoft Dragon Copilot: Combines ambient recording and dictation, so Suki does not have an exclusive advantage in offering both. Microsoft introduced reduced per-user pricing and simplified per-encounter consumption in mid-2026; older reseller quotations should not be treated as current Dragon Copilot pricing.
• Freed: Offers a clearer low-volume entry point, an unlimited-note Core tier, and a brief no-credit-card trial. Its Premier tier adds EHR push, dictation, coding, and patient materials, meaning adjacent workflow features are not exclusive to Suki. Published plan tiers and integration depth should be evaluated separately.
• Ambience, Nabla, and DeepScribe: Relevant additional shortlist candidates. Available public evidence was insufficient to rank their current specialty accuracy against Suki or establish a reliable like-for-like price comparison.

The concierge-practice interview favors Suki over historical iScribe editing economics. Conversely, a negative community post described being faster without Suki, while other users prefer DAX or Abridge. These comparisons show that workflow and personal note style can matter more than feature lists; they do not establish a universal winner.

No reliable market-share denominator was found. Funding announcements, partner disclosures, and vendor customer counts indicate commercial momentum but cannot, on their own, establish market leadership or production penetration.

Sources: Official vendor documentation and product pages; third-party review sites and seller listings; industry press coverage; community forums and user interviews.